12.31
price up icon6.49%   0.75
after-market Dopo l'orario di chiusura: 12.34 0.03 +0.24%
loading

Erasca Inc Borsa (ERAS) Ultime notizie

pulisher
Feb 12, 2026

Erasca (NASDAQ:ERAS) Trading Up 6.8%Should You Buy? - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Erasca stock reaches 52-week high at 12.48 USD - Investing.com

Feb 12, 2026
pulisher
Feb 12, 2026

ERAS: Early clinical data show promising efficacy and safety for next-generation pan-RAS and pan-KRAS inhibitors - TradingView

Feb 12, 2026
pulisher
Feb 11, 2026

Erasca Sees Unusually High Options Volume (NASDAQ:ERAS) - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

What sentiment indicators say about Erasca Inc. stock2025 Growth vs Value & Weekly Breakout Watchlists - mfd.ru

Feb 11, 2026
pulisher
Feb 09, 2026

Erasca (NASDAQ:ERAS) Sets New 1-Year HighStill a Buy? - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

Stifel reiterates Buy rating on Erasca stock, maintains $10 price target - Investing.com Nigeria

Feb 09, 2026
pulisher
Feb 09, 2026

Stifel reiterates Buy rating on Erasca stock, maintains $10 price target By Investing.com - Investing.com South Africa

Feb 09, 2026
pulisher
Feb 06, 2026

Erasca (ERAS) Hits Fresh High Anew as Firm Gets up to 267% PT Hike - MSN

Feb 06, 2026
pulisher
Feb 06, 2026

Erasca (ERAS) Is Up 15.2% After Upsized Offering Extends Cash Runway For RAS/MAPK Pipeline - simplywall.st

Feb 06, 2026
pulisher
Feb 05, 2026

Erasca (NASDAQ:ERAS) Trading 6.4% HigherHere's What Happened - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Erasca to Present at Upcoming Conferences in February - The Manila Times

Feb 05, 2026
pulisher
Feb 04, 2026

Erasca (ERAS) Price Target Increased by 60.94% to 10.51 - Nasdaq

Feb 04, 2026
pulisher
Feb 03, 2026

Erasca (ERAS) Is Up 10.4% After $225M Follow-On Offering And RAS Pipeline UpdatesHas The Bull Case Changed? - Yahoo Finance

Feb 03, 2026
pulisher
Feb 03, 2026

Erasca (NASDAQ:ERAS) Hits New 52-Week HighStill a Buy? - MarketBeat

Feb 03, 2026
pulisher
Feb 02, 2026

Erasca stock hits 52-week high at $10.71 By Investing.com - Investing.com Nigeria

Feb 02, 2026
pulisher
Feb 02, 2026

Erasca stock hits 52-week high at $10.71 - Investing.com India

Feb 02, 2026
pulisher
Feb 02, 2026

Up 460% in the Past Year, Should You Take a Gamble on This Speculative Stock? - Barchart.com

Feb 02, 2026
pulisher
Feb 02, 2026

Palmetto Grain Brokerage - Palmetto Grain Brokerage

Feb 02, 2026
pulisher
Feb 02, 2026

Mizuho initiates Erasca (ERAS) with 'outperform' rating and $16 PT - MSN

Feb 02, 2026
pulisher
Feb 02, 2026

Mizuho Initiates Erasca (ERAS) With 'Outperform' Rating and $16 PT - Finviz

Feb 02, 2026
pulisher
Feb 02, 2026

Mizuho Initiates Erasca (ERAS) With ‘Outperform’ Rating and $16 PT - Insider Monkey

Feb 02, 2026
pulisher
Jan 31, 2026

11 Best Performing Stocks in the Last 12 Months - Insider Monkey

Jan 31, 2026
pulisher
Jan 31, 2026

Guggenheim more than doubles Erasca (ERAS) PT following clinical progress and updated pipeline models - MSN

Jan 31, 2026
pulisher
Jan 30, 2026

Guggenheim More Than Doubles Erasca (ERAS) PT Following Clinical Progress and Updated Pipeline Models - Finviz

Jan 30, 2026
pulisher
Jan 29, 2026

Erasca extends cash runway after upsized public offering - TipRanks

Jan 29, 2026
pulisher
Jan 29, 2026

Erasca, Inc. Closes Upsized Public Offering - TradingView

Jan 29, 2026
pulisher
Jan 29, 2026

Does Erasca’s US$225 Million Equity Raise and ERAS-0015 Data Change The Bull Case For ERAS? - simplywall.st

Jan 29, 2026
pulisher
Jan 29, 2026

10 New Stocks on the Rise - Insider Monkey

Jan 29, 2026
pulisher
Jan 28, 2026

Guggenheim raises Erasca stock price target to $12 on RAS inhibitor progress - Investing.com UK

Jan 28, 2026
pulisher
Jan 27, 2026

Biotech Fundraising A Good Sign For Public Markets - Law360

Jan 27, 2026
pulisher
Jan 26, 2026

Erasca stock price target raised to $15 from $11 at H.C. Wainwright - Investing.com

Jan 26, 2026
pulisher
Jan 26, 2026

Revolution Medicines, Erasca And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Jan 26, 2026
pulisher
Jan 26, 2026

Why Is Cancer Drug Developer Erasca Stock Trading Lower Monday? - Benzinga

Jan 26, 2026
pulisher
Jan 26, 2026

Morgan Stanley Raises Price Target on Erasca to $10 From $4, Keeps Equalweight Rating - marketscreener.com

Jan 26, 2026
pulisher
Jan 25, 2026

Fundamentals Check: How does Erasca Inc perform in inflationary periods2025 Price Momentum & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 24, 2026

Erasca completes $258.8 million public offering of common stock By Investing.com - Investing.com Australia

Jan 24, 2026
pulisher
Jan 24, 2026

Erasca completes $258.8 million public offering of common stock - Investing.com India

Jan 24, 2026
pulisher
Jan 23, 2026

Investor Mood: Should I average down on Erasca Inc stock2025 Major Catalysts & Stock Portfolio Risk Control - baoquankhu1.vn

Jan 23, 2026
pulisher
Jan 23, 2026

Erasca Closes Public Offering - marketscreener.com

Jan 23, 2026
pulisher
Jan 23, 2026

Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times

Jan 23, 2026
pulisher
Jan 23, 2026

Erasca stock hits 52-week high at 10.46 USD By Investing.com - Investing.com Nigeria

Jan 23, 2026
pulisher
Jan 22, 2026

Erasca Announces Major Underwritten Public Equity Offering - TipRanks

Jan 22, 2026
$44.80
price up icon 1.24%
$26.75
price down icon 0.19%
$100.75
price up icon 1.93%
$105.76
price down icon 3.31%
$146.17
price down icon 1.52%
biotechnology ONC
$346.42
price down icon 1.38%
Capitalizzazione:     |  Volume (24 ore):